Entering an Era of More Personalized Treatment in Lung Cancer:
Increasing Patient Survival Rates

Presented by the Johns Hopkins University School of Medicine
4.0 AMA PRA Category 1 Credits™ available

Available Now On Demand


VIDEO PRESENTATIONS

Are We Ready to Move to Annual Screening for Lung Cancer in High Risk Patients?
  •  
Claudia I. Henschke, MD, Mount Sinai Medical Center

Recent Developments in Targeted Therapy for NSCLC
  •  David Jackman, MD, Harvard Medical School

Application of Advancements in Biomarker Identification to Clinical Practice in Patients with NSCLC. Is it Ready for Primetime?
  •  Peter Bela Illei, MD, Johns Hopkins Medicine Bayview Medical Center

Optimizing Therapy Choices in Patients with SCLC
  •  Jeffrey Crawford, Duke University Medical Center

Registration

* indicates a required field

Personal Information

Login Information

Professional Information

Other Information

Would you like to register for